|
 | 永赢医药健康A(008618)基金投资组合(持股) 年份： | | 截止日期 | 股票代码 | 股票名称 | 数量(万股) | 持有市值(万元) | 占基金资产净值比例(%) | | 2026-06-30 | 603259 | 药明康德 | 32.89 | 4095.13 | 105.17% | | 2026-06-30 | 688578 | 艾力斯 | 29.93 | 3267.98 | 83.92% | | 2026-06-30 | 688331 | 荣昌生物 | 23.37 | 3044.46 | 78.18% | | 2026-06-30 | 600276 | 恒瑞医药 | 52.81 | 2748.23 | 70.58% | | 2026-06-30 | 300347 | 泰格医药 | 44.56 | 2138.88 | 54.93% | | 2026-06-30 | 688235 | 百济神州 | 8.39 | 2135.29 | 54.84% | | 2026-06-30 | 688336 | 三生国健 | 38.93 | 2067.00 | 53.08% | | 2026-06-30 | 002755 | 奥赛康 | 144.54 | 1968.63 | 50.56% | | 2026-06-30 | 688046 | 药康生物 | 80.10 | 1938.51 | 49.78% | | 2026-06-30 | 300759 | 康龙化成 | 66.63 | 1927.61 | 49.50% | | 2026-06-30 | 688192 | 迪哲医药 | 43.62 | 1741.59 | 44.72% | | 2026-06-30 | 688131 | 皓元医药 | 16.12 | 1524.57 | 39.15% | | 2026-06-30 | 688266 | 泽璟制药 | 13.03 | 1519.58 | 39.02% | | 2026-06-30 | 300149 | 睿智医药 | 159.03 | 1517.14 | 38.96% | | 2026-06-30 | 301080 | 百普赛斯 | 31.49 | 1511.52 | 38.82% | | 2026-06-30 | 301393 | 昊帆生物 | 22.80 | 1476.76 | 37.92% | | 2026-06-30 | 002422 | 科伦药业 | 33.33 | 1283.87 | 32.97% | | 2026-06-30 | 688114 | 华大智造 | 20.86 | 1065.55 | 27.36% | | 2026-06-30 | 688256 | 寒武纪 | 0.65 | 1029.93 | 26.45% | | 2026-06-30 | 002353 | 杰瑞股份 | 5.79 | 882.98 | 22.68% | | 2026-06-30 | 688062 | 迈威生物 | 27.41 | 774.27 | 19.88% | | 2026-06-30 | 688795 | 摩尔线程 | 0.71 | 505.84 | 12.99% | | 2026-06-30 | 000657 | 中钨高新 | 5.19 | 496.79 | 12.76% | |
|